NEW YORK (GenomeWeb News) – Population Genetics Technologies today said that it has exclusively licensed patent rights covering its VeriTag technology to Agilent Technologies.

The deal covers US Patent No. 8,481,292, entitled "Increasing confidence of allele calls with molecular counting." Veritag quantifies genomic variants down to .1 percent, Population Genetics said on its website, adding it "relies on the ligation of random DNA tags to genomes" prior to PCR amplification "thus uniquely labeling each molecule."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.